Skip to main content

Table 1 Descriptive statistics of the clinical features (notably, age, BMI and inflammatory and metabolic parameters) of the 64 patients with breast cancer and 52 healthy controlsa

From: Using Resistin, glucose, age and BMI to predict the presence of breast cancer

 

Patients

Controls

p-value

Age (years)

53.0 (23.0)

65.0 (33.2)

0.479

BMI (kg/m2)

27.0 (4.6)

28.3 (5.4)

0.202

Glucose (mg/dL)

105.6 (26.6)

88.2 (10.2)

<0.001

Insulin (μU/mL)

12.5 (12.3)

6.9 (4.9)

0.027

HOMA

3.6 (4.6)

1.6 (1.2)

0.003

Leptin (ng/mL)

26.6 (19.2)

26.6 (19.3)

0.949

Adiponectin (μg/mL)

10.1 (6.2)

10.3 (7.6)

0.767

Resistin (ng/mL)

17.3 (12.6)

11.6 (11.4)

0.002

MCP-1(pg/dL)

563.0 (384.0)

499.7 (292.2)

0.504

  1. aValues are given as median (interquartile range). The p-values included in the table were obtained with Mann-Whitney U tests, after normality assumptions were assessed, for each variable, with a Shapiro-Wilk test. BMI body mass index, MCP-1 monocyte chemoattractant protein-1, HOMA homeostasis model assessment for insulin resistance